The Prognostic Value of Creatine Kinase-MB Dynamics after Primary Angioplasty in ST-Elevation Myocardial Infarctions

Delia Melania Popa1, Liviu Macovei1,2, Mihaela Moscalu3

  • 1Cardiology Department, Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Iași, Romania.

PubMed

Insights

Creatine Kinase-MB (CK-MB) levels in ST-elevation myocardial infarction (STEMI) patients predict short-term outcomes. Higher CK-MB levels correlate with reduced ejection fraction and increased mortality risk, aiding in complication prediction.

Area of Science:

  • Cardiology
  • Biomarkers
  • Myocardial Injury

Background:

  • The prognostic value of myocardial injury biomarkers in ST-elevation myocardial infarction (STEMI) requires further investigation.
  • While elevated creatine kinase-MB (CK-MB) is linked to mortality in STEMI patients undergoing angioplasty, its short-term prognostic implications are not fully understood.

Purpose of the Study:

  • To evaluate the relationship between CK-MB levels and short-term prognoses in STEMI patients.
  • To determine the predictive value of CK-MB for complications and mortality following STEMI.

Main Methods:

  • Retrospective analysis of data from 80 STEMI patients.
  • Categorization into groups based on acute complications and mortality.
  • Assessment of CK-MB levels upon admission, peak levels, and variation.

Main Results:

  • Elevated admission and peak CK-MB levels correlated with decreased left ventricular ejection fraction.
  • CK-MB variation predicted complications with a threshold of 388 U/L.
  • A CK-MB cut-off of 354 U/L predicted mortality.

Conclusions:

  • CK-MB levels serve as reliable indicators for STEMI patient outcomes.
  • The difference between peak and admission CK-MB levels accurately predicts complications.
  • CK-MB variation demonstrates significant predictive power for mortality risk in STEMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
174
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20